Home / Conferences / SMi 5th Annual Biosimilars USA Conference 2018

SMi 5th Annual Biosimilars USA Conference 2018 Posted 06/07/2018

SMi 5th Annual Biosimilars USA Conference 2018
14–15 November 2018
Renaissance Woodbridge Hotel, Iselin
New Jersey, USA

Building on the success of previous events, SMi proudly announces the return of its 5th Annual Biosimilars USA Conference, taking place in New Jersey on the 14th and 15th November 2018.

This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the US.

Fresh from the press: On 7 March 2018, the US Food and Administration’s (FDA) Commissioner, Dr Scott Gottlieb, announced that Biosimilar medicines are now a top priority for FDA. Join us this November to learn how to take advantage of FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval.

Hear from a selection of carefully hand-picked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability and regulations.

This event is CPD accredited.



Comments (0)